Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma
Leukemia Research, 06/21/2012
Fragioudaki M et al. – Higher B–cell activating factor (BAFF) levels predicted a shorter survival, suggesting an important prognostic marker and a possible therapeutic target in myeloma.



